AD

Abhijit Deka

Director Director DIN 06379622
DIN 06379622 First appointment Oct 2012 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Oct 2012
Shareholding value Locked Premium profile

About Abhijit Deka

Abhijit Deka has 13 years in corporate governance. Formerly with 1 company, such as Septy Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06379622
Primary Designation Director
First Appointment 01 Oct 2012
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Septy Pharmaceuticals Private Limited U24232AS2006PTC008149
Director 01 Oct 2012 2006 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Septy Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Abhijit Deka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhijit Deka

Abhijit Deka has 13 years in corporate governance. Formerly with 1 company, such as Septy Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Abhijit Deka is associated with 0 companies as a director.

Abhijit Deka has expertise in General Business.

Abhijit Deka has 13 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available